Annovis Bio, Inc.
NYSE:ANVSBiotechnology
Healthcare
$1.21 +0.00%
+$0.00 today
- Market cap
- $51.64M
- Beta
- 1.24
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$1.47
52W Low $1.54High $5.50
Volume 1.35M
Average 1.08M
Price history
Annovis Bio, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-68.81%
Period high
$5.10
Period low
$1.18
Latest
$1.21
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| DEF 14A | Sep 11, 2026 | Sep 11, 2026 | |
| PRE 14A | Aug 25, 2026 | Aug 24, 2026 | |
| 10-Q | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Jul 29, 2026 | Jul 29, 2026 | |
| 8-K | Jul 10, 2026 | Jul 9, 2026 | |
| 8-K | Jun 17, 2026 | Jun 17, 2026 | |
| 4 | May 21, 2026 | May 21, 2026 | |
| 8-K | May 20, 2026 | May 20, 2026 | |
| 424B5 | May 20, 2026 | May 20, 2026 | |
| 424B5 | May 19, 2026 | May 19, 2026 | |
| 8-K | May 15, 2026 | May 15, 2026 | |
| 10-Q | May 15, 2026 | May 15, 2026 | |
| DEF 14A | Apr 30, 2026 | Apr 30, 2026 |
Competitors
Who does Annovis Bio, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about ANVS's filings, answered from its disclosures.
What is the latest ANVS filing?
The latest filing shown is DEF 14A dated Sep 11, 2026.
How many recent filings does ANVS have?
Intrinsic Alpha currently shows 20 recent filings for ANVS.
Continue the stock analysis
Jump to another research area for this company.